Inhalation Anesthesia Market By Product (Sevoflurane, Isoflurane, And Desflurane), By Application (Induction And Maintenance), And By Region - Global Forecast To 2028
26th June 2019
- find_in_page Our Research Methodology is based on the following main points:
- Data Collections and Interpretation
- Data Validation
- Final Projections and Conclusion
The Global Inhalation Anesthesia market is expected to be valued at over US$ 1 Bn in 2019 and is expected to register a CAGR of 3.5% over the next 10 years. The global inhalation anesthesia market report has been segmented on the basis of product, application, and region.
Global Inhalation Anesthesia Market: Introduction
Inhalation anesthesia is a surgical procedure in which an anesthetic compound is administered to patient via inhalation. The anesthetic compound moves through a delivery system consisting of anesthetic vaporizer, a face mask, laryngeal mask airway or tracheal tube before being assimilated by patient’s body. Inhalation anesthesia is routinely used during most medical surgeries as the intensity of anesthesia is simpler to control and the patient regains his/her consciousness soon with few deleterious after-effects.
Global Inhalation Anesthesia Market: Dynamics
Rising number of emergencies due to increasing number of accidental cases, chronic diseases, and cataract cases is expected to boost demand for surgeries, and subsequently need for anesthesia procedures. For instance, according to a document published by the World Health Organization (WHO) in 2017, around 17.9 million people died from cardiovascular-related diseases in 2016, which was around 31% of total global deaths. In addition, it is predicted that 23.6 million people would be fatally affected by Cardiovascular disease (CVD), Coronary heart disease (CHD), and other heart diseases by 2030.
Further, certain advantages offered by inhalation anesthesia such as low risk of adverse chemical reactions and lower chances of complications during administration as compared with Intravenous Anesthesia (IVA), makes the target product popular among medical practitioners. In addition, inhalational anesthesia helps avoid excessive dosage, keeps the patient’s autonomic functions intact, prevents accumulation of drugs in the body and have limited tolerance and addiction level as compared to conventional routes.
Furthermore, increasing investments in R&D, by leading manufacturers in order to develop technologically advanced products such as airway pressure monitoring and breathing system disconnect alarms, monitoring of inspired oxygen, pulse oximetry, etc., is expected to support growth of the global inhalation anesthesia market in next 10 years.
However, high cost of inhalation anesthesia procedure and lack of well-trained surgeons may hamper growth for the target market.
Global Inhalation Anesthesia Market Analysis by Product:
Currently, among segments based on product, the sevoflurane segment dominates in the global inhalation anesthesia market with major revenue share. Better therapeutic effects and low cost make Sevoflurane most popular among surgeons and patients. Chemically, sevoflurane is an ether with low pungency, a low blood-gas partition co-efficient, and a non-irritant odor. The sevoflurane segment is projected to grow at a significant growth rate over the forecast period and maintain its dominance in the next 10 years.
Global Inhalation Anesthesia Market Analysis, by Application:
Currently, among segments based on application, the maintenance segment dominates in the global inhalation anesthesia market. This can be attributable to higher requirement of anesthesia for maintenance as compared with induction. The maintenance segment is also anticipated to maintain its dominance over the forecast period owing to a significant CAGR over the forecast period.
Global Inhalation Anesthesia Market Analysis by Region:
Currently, among segments based on region, the North America market accounts for a major share in the global inhalation anesthesia market in terms of revenue. This can be attributed to increasing cases of chronic diseases associated with modern lifestyle and widespread healthcare system consisting of a network of public and private hospitals.
The Asia Pacific market is projected to register a considerable growth rate of over 3.4% over the next 10 years. Key factors that are expected to drive rapid growth of the target market in this region include increasing population, growing public and private healthcare investments, and rapidly growing medical tourism industry. According to a WHO report in 2017, it was estimated that about 39.5 million surgeries were performed in China. Further, as per the report of Brink Asia Pacific Risk Center in 2017, around 4 Million medical tourists traveled to India to seek health care services, 3.5 million foreign patients traveled to Thailand, and 900,000 patients to Singapore in 2016.
Global Inhalation Anesthesia Market Segmentation:
Segmentation, by Product:
Segmentation, by Application:
Segmentation, by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- AbbVie Inc.
- Piramal Healthcare
- Lunan Pharmaceuticals
- Halocarbon Products Corporation
- Troikaa Pharmaceuticals Ltd.
- Baxter International Inc.
- Fresenius Kabi AG
- Jiangsu Hengrui Medicine Co. Ltd.
- Maruishi Pharmaceutical Co. Ltd.
- Merck KGaA
- 1.1 Report Assumptions
- 1.2 Research Methodology
- 22.214.171.124 Abbreviations
- 2.1 Introduction
- 2.2 Executive Summary
- 2.3 Drivers
- 2.4 Global Inhalation Anesthesia Market Outlook (2012-2028)
- 2.4.1 Global Inhalation Anesthesia Revenue (US$ Mn) (2012–2019)
- 2.4.2 Global Inhalation Anesthesia Revenue (US$ Mn) (2020–2028)
- 2.5 Global Inhalation Anesthesia Revenue by Regions
Request for Customization
Don't just take our word. We are trusted by these great companies!